We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
-7.89%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
-$29.7M
Cap. Flow
+$110M
Cap. Flow %
10.28%
Top 10 Hldgs %
55.73%
Holding
349
New
26
Increased
163
Reduced
134
Closed
15

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$35.5M
2
GRAB icon
Grab
GRAB
+$33.3M
3
QCOM icon
Qualcomm
QCOM
+$25.7M
4
AMD icon
Advanced Micro Devices
AMD
+$21.8M
5
SE icon
Sea Limited
SE
+$18.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.29%
2 Technology 26.19%
3 Communication Services 11.91%
4 Healthcare 11.24%
5 Real Estate 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
251
Linde
LIN
$236B
$269K 0.03%
996
-4
-0.4% -$1.15K
SWKS icon
252
Skyworks Solutions
SWKS
$9.28B
$269K 0.03%
3,149
-76
-2% -$7.77K
KURA icon
253
Kura Oncology
KURA
$948M
$265K 0.02%
19,380
+8,807
+83% +$136K
AGIO icon
254
Agios Pharmaceuticals
AGIO
$2.28B
$264K 0.02%
9,340
-4,333
-32% -$116K
ALT icon
255
Altimmune
ALT
$558M
$264K 0.02%
+20,640
New +$305K
COP icon
256
ConocoPhillips
COP
$144B
$262K 0.02%
2,559
-14
-0.5% -$1.4K
PM icon
257
Philip Morris
PM
$302B
$261K 0.02%
3,139
+61
+2% +$5.82K
DCPH
258
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$257K 0.02%
13,887
-4,066
-23% -$63.8K
ZTS icon
259
Zoetis
ZTS
$32B
$256K 0.02%
1,725
+180
+12% +$30.1K
BIDU icon
260
Baidu
BIDU
$36.1B
$254K 0.02%
2,166
+102
+5% +$13.9K
DDOG icon
261
Datadog
DDOG
$91.5B
$254K 0.02%
2,866
+163
+6% +$16.4K
HUM icon
262
Humana
HUM
$46.3B
$254K 0.02%
523
+49
+10% +$23.8K
KPTI icon
263
Karyopharm Therapeutics
KPTI
$175M
$251K 0.02%
3,062
-449
-13% -$33.5K
KRYS icon
264
Krystal Biotech
KRYS
$10.1B
$250K 0.02%
3,591
-217
-6% -$15.7K
SYK icon
265
Stryker
SYK
$129B
$250K 0.02%
1,232
+108
+10% +$22.7K
RCKT icon
266
Rocket Pharmaceuticals
RCKT
$369M
$249K 0.02%
+15,578
New +$243K
LOW icon
267
Lowe's Companies
LOW
$118B
$246K 0.02%
1,308
-5
-0.4% -$974
SNDX icon
268
Syndax Pharmaceuticals
SNDX
$1.91B
$242K 0.02%
+10,064
New +$226K
UNP icon
269
Union Pacific
UNP
$181B
$242K 0.02%
1,243
-4
-0.3% -$885
RTX icon
270
RTX Corp
RTX
$293B
$241K 0.02%
2,943
-10
-0.3% -$905
UPS icon
271
United Parcel Service
UPS
$97.4B
$239K 0.02%
1,482
+23
+2% +$4.36K
EBAY icon
272
eBay
EBAY
$48.6B
$238K 0.02%
6,459
BDX icon
273
Becton Dickinson
BDX
$43.6B
$237K 0.02%
1,062
+99
+10% +$24.6K
OCGN icon
274
Ocugen
OCGN
$440M
$237K 0.02%
132,938
-25,946
-16% -$64.6K
PMVP icon
275
PMV Pharmaceuticals
PMVP
$64.5M
$237K 0.02%
19,884
-7,617
-28% -$110K

Similar funds

E Fund Management's Q3 2022 Portfolio in Review

As of Q3 2022, E Fund Management held 349 positions worth $1.07B, down 2.7% from $1.1B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

E Fund Management deployed $110M of net new capital in Q3 2022, opening 26 new positions and adding to 163 existing holdings. Its largest new stake was TSMC: 430,000 shares worth $29.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, down from 36% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Mercado Libre, an estimated $26.6M trimmed.

  • E Fund Management's largest Q3 2022 buy was TSMC: 430,000 shares worth $29.5M.
  • E Fund Management added most to Grab in Q3 2022, an estimated $33.3M increase.
  • E Fund Management's biggest Q3 2022 reduction was Mercado Libre, cutting an estimated $26.6M.
  • E Fund Management fully exited DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share in Q3 2022, selling an estimated $6.5M.
  • E Fund Management's ten largest holdings make up 56% of its $1.07B portfolio in Q3 2022.
  • E Fund Management opened 26 new positions and closed 15 in Q3 2022.
  • E Fund Management's portfolio value fell 2.7% quarter-over-quarter to $1.07B.

Based on E Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.